Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xtant Medical Holdings (XTNT)
NYSE MKT:XTNT
RESEARCH TOOLSreports
Holding XTNT?
Track your performance easily
XTNT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.60 - $1.45
Previous Close$0.71
Volume46.93K
Average Volume (3M)88.71K
Market Cap
$92.49M
Enterprise Value$116.70M
Total Cash (Recent Filing)$4.55M
Total Debt (Recent Filing)$28.76M
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Aug 01, 2024EPS Estimate
-$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding130,216,541
10 Day Avg. Volume60,094
30 Day Avg. Volume88,707
Standard Deviation0.34
R-Squared0.00268
Alpha0.00893
Financial Highlights & Ratios
Price to Book (P/B)1.74
Price to Sales (P/S)0.97
Price to Cash Flow (P/CF)-24.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.15
Enterprise Value/Gross Profit2.10
Enterprise Value/Ebitda32.39
Forecast
1Y Price Target
$2.35Price Target Upside225.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Xtant Medical Holdings News
PremiumCompany Announcements
Xtant Medical Reports Q3 2024 Revenue Growth and New Product Launches
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
XTNT FAQ
What was Xtant Medical Holdings’s price range in the past 12 months?
Xtant Medical Holdings lowest stock price was $0.60 and its highest was $1.45 in the past 12 months.
What is Xtant Medical Holdings’s market cap?
Currently, no data Available
When is Xtant Medical Holdings’s upcoming earnings report date?
Xtant Medical Holdings’s upcoming earnings report date is Aug 01, 2024 which is 112 days ago.
How were Xtant Medical Holdings’s earnings last quarter?
Currently, no data Available
Is Xtant Medical Holdings overvalued?
According to Wall Street analysts Xtant Medical Holdings’s price is currently Undervalued.
Does Xtant Medical Holdings pay dividends?
Xtant Medical Holdings does not currently pay dividends.
What is Xtant Medical Holdings’s EPS estimate?
Xtant Medical Holdings’s EPS estimate is -$0.02.
How many shares outstanding does Xtant Medical Holdings have?
Xtant Medical Holdings has 130,268,590 shares outstanding.
What happened to Xtant Medical Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Xtant Medical Holdings?
Currently, no hedge funds are holding shares in XTNT
---
Xtant Medical Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.91%
12-Months-Change
Fundamentals
Return on Equity
-4.13%
Trailing 12-Months
Asset Growth
48.35%
Trailing 12-Months
Company Description
Xtant Medical Holdings
Xtant Medical Holdings, Inc. operates as a holding company, which supplies orthopedic and spine surgery products. The firm operates through its subsidiaries, Bacterin International, Inc. and X-spine Systems, Inc. Bacterin International develops, manufactures, and markets biologics products to domestic and international markets. Its products are bone graft, which are used in promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries; and custom surgical products used for allografts. X-spine Systems is a manufacturer of implants and instruments for surgery of the spine and sacroiliac joint. Its products are used for the treatment of degenerative spine disorders. The company was founded in 2006 and is headquartered in Belgrade, MT.
---
XTNT Earnings Call
Q1 2024
0:00 / 0:00
---
XTNT Stock 12 Month Forecast
Average Price Target
$2.35
▲(225.15% Upside)
Technical Analysis
Best Analysts Covering XTNT
1 Year
1 Year Success Rate
3/8 ratings generated profit
1 Year Average Return
-9.04%
reiterated a buy rating 6 months ago
Copying Chase Knickerbocker's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -9.04% per trade.
---